Related Experiment Video
Updated: Oct 1, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
Bupivacaine Metabolite Can Interfere with Norfentanyl Measurement by LC-MS/MS
Grace Mahowald1, Tahira Khaliq1, Sankha Basu2
1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
N-desbutyl bupivacaine (NDB) interferes with fentanyl metabolite (NF) detection using LC-MS/MS. A unique NF product ion (177 m/z) is critical for accurate identification, preventing misdiagnosis in patient care.
Area of Science:
- Analytical Chemistry
- Clinical Chemistry
- Pharmacology
Background:
- Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) is the preferred method for quantifying fentanyl and its metabolite, norfentanyl (NF), in urine due to high specificity.
- Norfentanyl (NF) is the primary urinary metabolite of fentanyl and is usually found at higher concentrations, making its accurate detection crucial for drug monitoring.
- The accuracy of LC-MS/MS assays for NF relies heavily on the precise identification and quantification of this metabolite.
Purpose of the Study:
- To investigate the interference of N-desbutyl bupivacaine (NDB), a metabolite of bupivacaine used in epidural analgesia, with the LC-MS/MS assay for urinary norfentanyl (NF).
- To identify analytical strategies to differentiate NDB from NF in urine specimens analyzed by LC-MS/MS.
Main Methods:
- Urine specimens from laboring women receiving epidural analgesia with bupivacaine and fentanyl were analyzed using LC-MS/MS.
- The interference of N-desbutyl bupivacaine (NDB) with the quantification of norfentanyl (NF) was assessed by examining shared precursor and product ions.
- A unique product ion specific to NF was identified to distinguish it from NDB.
Main Results:
- N-desbutyl bupivacaine (NDB) was found to interfere with the LC-MS/MS assay for norfentanyl (NF).
- NDB shares the same precursor ion (233 m/z) and key product ions (84 m/z, 150 m/z) as NF, hindering accurate quantification.
- A unique NF product ion (177 m/z) was identified, enabling differentiation between NDB and NF.
Conclusions:
- Laboratories must recognize the interference of N-desbutyl bupivacaine (NDB) in LC-MS/MS assays for norfentanyl (NF).
- Accurate identification of NF, facilitated by the 177 m/z product ion, is critical to prevent misidentification and ensure appropriate patient care.
- Failure to account for NDB interference can lead to significant misinterpretations of fentanyl metabolite levels.
Related Concept Videos
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Opioid Analgesics: Synthetic and Semisynthetic Opioids

